US$ 29.14
glp-1 agonists thyroid cancer Receptor in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways GLP-1RA and thyroid cancer: New
Description
Ma et al

Sanofi is also dealing with the decline in insulin sales due to newer insulin products and biosimilars, which puts pressure on its pipeline

10.1016/j.ajpath.2024.12.003 63 TangH.LuY.OkunM

This could pave the way for innovative integrated treatment strategies to improve outcomes for patients affected by these intertwined conditions
